Biomarker testing can help match patients with cancer to the most effective treatment or clinical trial, and results matter most when they’re available before treatment begins. Coverage laws are opening the door. Too many patients still never walk through it.
Gregory Vidal, MD, PhD, of West Cancer Center and Maddie Bushnell of the American Cancer Society Cancer Action Network join host Carla Baker, RN, Chair of the Memphis Area Cancer Consortium, to discuss closing the gap between coverage and care in Tennessee. The full agenda will be shared soon.
Featured clinicians and speakers disclose relevant relationships. AHIS selects all speakers and content.
Biomarker testing can help match patients with cancer to the most effective treatment or clinical trial, and results matter most when they’re available before treatment begins. Coverage laws are opening the door. Too many patients still never walk through it.
Gregory Vidal, MD, PhD, of West Cancer Center and Maddie Bushnell of the American Cancer Society Cancer Action Network join host Carla Baker, RN, Chair of the Memphis Area Cancer Consortium, to discuss closing the gap between coverage and care in Tennessee. The full agenda will be shared soon.
Featured clinicians and speakers disclose relevant relationships. AHIS selects all speakers and content.